UnitedHealth Group Incorporated

NYSE:UNH Stock Report

Market Cap: US$379.6b

UnitedHealth Group Valuation

Is UNH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of UNH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: UNH ($428.19) is trading below our estimate of future cash flow value ($960.28)

Significantly Below Future Cash Flow Value: UNH is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for UNH?

Key metric: As UNH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for UNH. This is calculated by dividing UNH's market cap by their current earnings.
What is UNH's PE Ratio?
PE Ratio32.3x
EarningsUS$12.04b
Market CapUS$379.60b

Price to Earnings Ratio vs Peers

How does UNH's PE Ratio compare to its peers?

The above table shows the PE ratio for UNH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average39.7x
ELV Elevance Health
17.3x12.15%US$88.6b
HUM Humana
41.9x26.97%US$47.2b
MOH Molina Healthcare
64.5x32.65%US$11.9b
HQY HealthEquity
35.1x14.12%US$8.1b
UNH UnitedHealth Group
32.3x16.11%US$379.6b

Price-To-Earnings vs Peers: UNH is good value based on its Price-To-Earnings Ratio (32.3x) compared to the peer average (39.7x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does UNH's PE Ratio compare vs other companies in the US Healthcare Industry?

7 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CYH Community Health Systems
1.1x-109.55%US$498.47m
IDXG Interpace Biosciences
1.9xn/aUS$45.71m
NIVF NewGenIvf Group
0.4xn/aUS$5.00m
RHEP Regional Health Properties
1.1xn/aUS$4.13m
UNH 32.3xIndustry Avg. 25.0xNo. of Companies11PE020406080100+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: UNH is expensive based on its Price-To-Earnings Ratio (32.3x) compared to the US Healthcare industry average (25x).

Price to Earnings Ratio vs Fair Ratio

What is UNH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

UNH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio32.3x
Fair PE Ratio42.6x

Price-To-Earnings vs Fair Ratio: UNH is good value based on its Price-To-Earnings Ratio (32.3x) compared to the estimated Fair Price-To-Earnings Ratio (42.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst UNH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$428.19
US$418.04
-2.37%
12.14%US$492.00US$287.00n/a26
Jul ’27US$426.54
US$411.88
-3.44%
13.04%US$492.00US$287.00n/a26
Jun ’27US$379.86
US$401.46
+5.69%
11.76%US$492.00US$287.00n/a26
May ’27US$368.78
US$387.27
+5.01%
10.48%US$444.00US$287.00n/a26
Apr ’27US$273.98
US$357.81
+30.60%
12.23%US$440.00US$255.00n/a26
Mar ’27US$293.27
US$364.63
+24.33%
11.85%US$440.00US$255.00n/a24
Feb ’27US$286.93
US$371.12
+29.34%
11.86%US$440.00US$280.00n/a25
Jan ’27US$330.11
US$392.24
+18.82%
11.17%US$440.00US$280.00n/a25
Dec ’26US$323.21
US$386.72
+19.65%
14.47%US$440.00US$198.00n/a25
Nov ’26US$341.56
US$385.40
+12.84%
15.05%US$440.00US$198.00n/a25
Oct ’26US$348.30
US$328.83
-5.59%
17.04%US$440.00US$198.00n/a24
Sep ’26US$309.87
US$316.04
+1.99%
15.20%US$440.00US$198.00n/a24
Aug ’26US$237.77
US$323.29
+35.97%
15.77%US$440.00US$198.00n/a24
Jul ’26US$326.14
US$383.96
+17.73%
18.56%US$626.00US$270.00US$426.5425
Jun ’26US$301.91
US$397.36
+31.62%
19.36%US$626.00US$270.00US$379.8625
May ’26US$400.68
US$552.84
+37.98%
8.41%US$677.00US$490.00US$368.7826
Apr ’26US$523.12
US$628.30
+20.11%
6.09%US$700.00US$518.76US$273.9826
Mar ’26US$474.96
US$637.24
+34.17%
4.77%US$700.00US$590.00US$293.2726
Feb ’26US$542.49
US$637.24
+17.47%
4.77%US$700.00US$590.00US$286.9326
Jan ’26US$505.86
US$636.59
+25.84%
4.65%US$700.00US$587.12US$330.1126
Dec ’25US$610.20
US$628.35
+2.98%
5.73%US$715.00US$550.00US$323.2126
Nov ’25US$567.56
US$618.87
+9.04%
4.65%US$658.00US$550.00US$341.5626
Oct ’25US$583.30
US$622.38
+6.70%
4.78%US$680.00US$550.00US$348.3025
Sep ’25US$590.20
US$621.94
+5.38%
4.85%US$680.00US$550.00US$309.8725
Aug ’25US$572.77
US$614.72
+7.32%
5.66%US$680.00US$545.00US$237.7725
Jul ’25US$494.65
US$575.77
+16.40%
6.35%US$675.00US$481.00US$326.1428
US$418.04
Fair Value
2.4% overvalued intrinsic discount
26
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 03:58
End of Day Share Price 2026/07/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

UnitedHealth Group Incorporated is covered by 44 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Hua HaBaird
Andrew MokBarclays